COVID-19 and Contact Tracing Apps: Ethical Challenges for a Social Experiment on a Global Scale.


Journal

Journal of bioethical inquiry
ISSN: 1872-4353
Titre abrégé: J Bioeth Inq
Pays: Netherlands
ID NLM: 101250741

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 05 05 2020
accepted: 03 08 2020
pubmed: 26 8 2020
medline: 2 1 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

Mobile applications are increasingly regarded as important tools for an integrated strategy of infection containment in post-lockdown societies around the globe. This paper discusses a number of questions that should be addressed when assessing the ethical challenges of mobile applications for digital contact-tracing of COVID-19: Which safeguards should be designed in the technology? Who should access data? What is a legitimate role for "Big Tech" companies in the development and implementation of these systems? How should cultural and behavioural issues be accounted for in the design of these apps? Should use of these apps be compulsory? What does transparency and ethical oversight mean in this context? We demonstrate that responses to these questions are complex and contingent and argue that if digital contract-tracing is used, then it should be clear that this is on a trial basis and its use should be subject to independent monitoring and evaluation.

Identifiants

pubmed: 32840842
doi: 10.1007/s11673-020-10016-9
pii: 10.1007/s11673-020-10016-9
pmc: PMC7445718
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

835-839

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Références

J Med Internet Res. 2009 Mar 27;11(1):e11
pubmed: 19329408
PLoS Med. 2011 Aug;8(8):e1001083
pubmed: 21918643
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
PLoS Comput Biol. 2012;8(7):e1002616
pubmed: 22844241
PLoS Comput Biol. 2011 Oct;7(10):e1002199
pubmed: 22022249
J Med Ethics. 2020 Jul;46(7):427-431
pubmed: 32366705

Auteurs

Federica Lucivero (F)

Ethox and Wellcome Centre for Ethics and Humanities, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, UK. Federica.lucivero@ethox.ox.ac.uk.

Nina Hallowell (N)

Ethox and Wellcome Centre for Ethics and Humanities, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, UK.

Stephanie Johnson (S)

Ethox and Wellcome Centre for Ethics and Humanities, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Oxford, UK.

Barbara Prainsack (B)

Department of Political Science, University of Vienna, Vienna, Austria.
Department of Global Health and Social Medicine, King's College London, London, UK.

Gabrielle Samuel (G)

Department of Global Health and Social Medicine, King's College London, London, UK.

Tamar Sharon (T)

Department of Practical Philosophy & Interdisciplinary Hub for Security, Privacy and Data Governance, Radboud University, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH